These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31606990)

  • 1. [The value of multi-gene testing in benign or malign diagnosis of thyroid nodules with indeterminate cytology].
    Song YT; Xu GH; Zhu YL; Ma TH; Yu H; Wang TX; Yu WB; Wei W; Zhang B
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Oct; 54(10):764-768. PubMed ID: 31606990
    [No Abstract]   [Full Text] [Related]  

  • 2. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma?
    Lei L; Hong Qing S; Wei L; Ma Mo Yang F; Xiao Xiang Y
    Am Surg; 2024 Dec; 90(12):3209-3215. PubMed ID: 39047144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAF
    Chen H; Song A; Wang Y; He Y; Tong J; Di J; Li C; Zhou Z; Cai X; Zhong D; Da J
    Cancer Med; 2022 Jan; 11(1):40-49. PubMed ID: 34851044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical role of BRAF V600E mutation testing in thyroid nodules].
    Wan H; Zhang B; Wang Y; Xiao T; Guo H; Liu W; Yan D; Xu Z; Tang P
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun; 49(6):468-72. PubMed ID: 25241863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of
    Chen X; Zhou Q; Wang F; Zhang F; Du H; Zhang Q; Wu W; Gong X
    AJNR Am J Neuroradiol; 2018 Dec; 39(12):2360-2365. PubMed ID: 30498021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does addition of BRAF V600E mutation testing modify sensitivity or specificity of the Afirma Gene Expression Classifier in cytologically indeterminate thyroid nodules?
    Kloos RT; Reynolds JD; Walsh PS; Wilde JI; Tom EY; Pagan M; Barbacioru C; Chudova DI; Wong M; Friedman L; LiVolsi VA; Rosai J; Lanman RB; Kennedy GC
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E761-8. PubMed ID: 23476074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
    Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
    Li X; Du H; Luo J; Ding W; Lai B; He J; Xu S; Zhang Y
    J Clin Lab Anal; 2020 Nov; 34(11):e23458. PubMed ID: 32671901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial clinical experience with BRAF(V600E) mutation analysis of core-needle biopsy specimens from thyroid nodules.
    Choi SH; Baek JH; Lee JH; Choi YJ; Ha EJ; Song DE; Kim JK; Chung KW; Kim TY; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):607-13. PubMed ID: 26215382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY; Shin JH; Ko EY; Han BK
    AJR Am J Roentgenol; 2012 Apr; 198(4):891-5. PubMed ID: 22451557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF V600E mutation analysis of thyroid nodules needle aspirates in relation to their ultrasongraphic classification: a potential guide for selection of samples for molecular analysis.
    Nam SY; Han BK; Ko EY; Kang SS; Hahn SY; Hwang JY; Nam MY; Kim JW; Chung JH; Oh YL; Shin JH
    Thyroid; 2010 Mar; 20(3):273-9. PubMed ID: 20187782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH; Song KH; Kim SK; Park KS; Yoo YB; Yang JH; Hwang TS; Kim DL
    Clin Endocrinol (Oxf); 2015 May; 82(5):760-6. PubMed ID: 25109485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency.
    Agretti P; Niccolai F; Rago T; De Marco G; Molinaro A; Scutari M; Di Cosmo C; Di Coscio G; Vitale M; Maccheroni M; Vitti P; Tonacchera M
    J Endocrinol Invest; 2014 Oct; 37(10):1009-14. PubMed ID: 25194426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
    Kim SY; Kim EK; Kwak JY; Moon HJ; Yoon JH
    Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
    Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of a multigene testing for preoperative evaluation of indeterminate thyroid nodules: A prospective blinded single center study in China.
    Song Y; Xu G; Ma T; Zhu Y; Yu H; Yu W; Wei W; Wang T; Zhang B
    Cancer Med; 2020 Nov; 9(22):8397-8405. PubMed ID: 32976686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A five-gene panel refines differential diagnosis of thyroid nodules.
    Lu SY; Chen YC; Zhu CF; Chen J; Zhou QY; Zhang MM; Zhang QY; Lu M; Yang L; Wu J; Zhao SX; Song HD; Ye XP
    J Clin Lab Anal; 2021 Sep; 35(9):e23920. PubMed ID: 34318534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing for BRAF (V600E) Mutation in Thyroid Nodules with Fine-Needle Aspiration (FNA) Read as Suspicious for Malignancy (Bethesda V, Thy4, TIR4): a Systematic Review and Meta-analysis.
    Trimboli P; Scappaticcio L; Treglia G; Guidobaldi L; Bongiovanni M; Giovanella L
    Endocr Pathol; 2020 Mar; 31(1):57-66. PubMed ID: 31811566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Next Generation Sequencing with ThyroSeq v2.1 for Indeterminate Thyroid Nodules in Clinical Practice.
    Witt RL
    Del Med J; 2016 Dec; 88(12):366-372. PubMed ID: 29461717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.